 |
|
New targets for type 2-low asthma
Quang Luu Quoc, Youngwoo Choi, Gyu-Young Hur, Hae-Sim Park
Korean J Intern Med. 2024;39(2):215-227. Published online 2024 Feb 6 DOI: https://doi.org/10.3904/kjim.2023.299
|
|
Citations to this article as recorded by
 Modernizing Asthma Diagnostics: Biosensors Enhanced by Nanomaterials and Artificial Intelligence
Anam Nizam, Mohd Rahil Hasan, Sana Khan, Saima Kamal, Manal Naved, Atul Kumar, Onaiza Ansari, Adib Khan, Jagriti Narang, Humaira Farooqi
Journal of Nanotheranostics.2026; 7(3): 16. CrossRef T2-Low Asthma: Mechanistic Pathways, Biomarkers, and Emerging Therapeutic Strategies
Georgios I. Barkas, Ourania S. Kotsiou, Evdoxia Gouta, Zoe Daniil, Garyfallia-Eirini Perlepe
Journal of Asthma.2026; : 1. CrossRef Updated biomarkers for extracellular traps from neutrophil, monocyte, and M1 macrophage in neutrophilic asthma: a narrative review
Quoc Quang Luu, Thi Bich Tra Cao, Hae-Sim Park, Duy Le Pham
MedPharmRes.2025; 9(1): 1. CrossRef Established and Emerging Asthma Biomarkers with a Focus on Biologic Trials: A Narrative Review
Philip F. Lavere, Kaitlin M. Phillips, Nicola A. Hanania, Muhammad Adrish
Journal of Personalized Medicine.2025; 15(8): 370. CrossRef Breaking the steroid barrier: Emerging biomarkers and targeted therapies for type 2-low asthma
Rahul Garg
Annals of the National Academy of Medical Sciences (India).2025; 61: 329. CrossRef Association of Peripheral Blood Eosinophils and Neutrophils with Asthma Phenotype among School-Aged Children
Jafar Wafi Janak, Hawraa Fadhil Abbas, Haidar A.N. Abood, Suhaila Rayhaan
Journal of Preventive, Diagnostic and Treatment Strategies in Medicine.2025; 4(4): 334. CrossRef T cell heterogeneity in asthma pathogenesis: from immunological mechanisms to biological targeted therapies
Qifeng Gan, Yuzhen Zhu, Yuxin Guo, Guo Fu, Xiao-Bin Zhang
Frontiers in Immunology.2025;[Epub] CrossRef
|